Renx Enterprises Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on June 10, 2026, and June 11, 2026, for Renx Enterprises Corp. (Renx), a Delaware corporation trading on The Nasdaq Stock Market under the symbol "RENX." The filing details a material debt-for-equity exchange with a related party and the results of the Company's 2026 Annual Meeting of Stockholders held on June 12, 2026.
Key Financial Metrics and Capital Structure Changes
- Debt Reduction: Renx cancelled $7,169,072.79 of principal and accrued interest outstanding under an Amended and Restated Promissory Note.
- Equity Issuance: In exchange for the debt, the Company issued 7,169 shares of Series C Convertible Preferred Stock and a warrant to purchase up to 619,084 shares of common stock.
- Conversion Potential: The Preferred Stock is convertible into up to 2,476,338.51 shares of common stock at an initial price of $2.895 per share. If the conversion price is reduced to the floor price of $1.50, the total potential issuance could reach 4,779,333 shares.
- Liquidity and Cash Flow: The filing does not provide specific cash flow, revenue, or profit metrics for the period. The transaction was structured as a non-cash exchange, avoiding immediate cash outflow for debt repayment.
Material Changes and Corporate Actions
- Debt-to-Equity Swap: The Company entered into an Exchange Agreement with Index Equity US, LLC (a related party managed by Director Bjarne Borg) to convert outstanding debt into equity securities.
- Stockholder Approvals: At the Annual Meeting, stockholders approved several critical proposals:
- Authorization to issue up to 862,335 shares from February warrant exercises.
- Authorization to issue up to 26,779,029 shares from the conversion of existing April Notes ($13.0 million principal).
- Authorization to issue up to 179,213,485 shares from future Additional April Notes ($87.0 million principal).
- Approval of a reverse stock split at a ratio of 1-for-5 to 1-for-10, to be determined by the Board.
- Amendment to the 2023 Incentive Compensation Plan, increasing authorized shares from 138,861 to 520,000.
- Director Elections: James D. Burnham and Peter G. DeMaria were elected as Class III directors.
Outlook, Risks, and Contingencies
- Dilution Risk: The approved proposals authorize the potential issuance of over 206 million shares of common stock upon conversion of notes and warrants, subject to beneficial ownership limitations (4.99% cap, adjustable to 19.99%).
- Preferred Stock Terms: The Series C Preferred Stock carries an 8% annual dividend rate (compounding quarterly), increasing to 9% if unpaid in cash. It includes a full-ratchet anti-dilution provision subject to a $1.50 floor price.
- Delisting Contingency: If Renx is delisted from Nasdaq for 30+ consecutive days, the Debtholder may elect to exchange the Preferred Shares back into an unsecured promissory note bearing 10% annual interest with a 24-month maturity.
- Redemption Rights: Holders may redeem shares after three years at 110% of stated value plus accrued dividends. The Company may redeem after 24 months at 115% (24-36 months) or 110% (after 36 months) of stated value.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-transaction to assess the impact of the 4.99% beneficial ownership limitation on future conversions.
- Confirm the specific reverse stock split ratio (1-for-5 to 1-for-10) once announced by the Board.
- Review the full text of the Certificate of Designation (Exhibit 3.1) and Exchange Agreement (Exhibit 10.1) for detailed anti-dilution mechanics and voting rights.
- Monitor the Company's ability to maintain Nasdaq listing compliance given the significant potential share issuance authorized by stockholders.
- Check for any subsequent filings regarding the exercise of the warrants or conversion of the April Notes.